Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trifarotene Cream 0.005% vs AKLIEF in Acne Vulgaris
NCT06063473Phase 1Completed
- Start
- Feb 2023
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of CD5789 cream vehicle in acne vulgaris (3 arms). Primary endpoint: Demonstration in Therapeutic Equivalence & Safety of the Investigational Product at 12 weeks. Started Feb 2023; status: completed.
02
Drugs
CD5789 cream vehicle
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT06063473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06063473.